Attenuation of changes in Gi -proteins and adenylyl cyclase in heart failure by an ACE inhibitor, imidapril

Journal of Cellular and Molecular Medicine

Volumn 7, Issue 3, 2003, Pages 277-286

  Sethi, R ^a   Shao, Q ^a   Takeda, N ^b   Dhalla, N S ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Jikei University Katsushika Medical Center   (Japan)

^c ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Angiotensin converting enzyme; Congestive heart failure; G proteins, adenylyl cyclase; Myocardial infarction; receptor density

Indexed keywords

ADENYLATE CYCLASE; CHOLERA TOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG RECEPTOR; FLUORIDE SODIUM; FORSKOLIN; IMIDAPRIL; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PERTUSSIS TOXIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE FUNCTION; MALE; MEMBRANE; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALIA;

EID: 0242438621     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2003.tb00228.x     Document Type: Article

References (42)

1. Bristow M.R., Laser J.A., Ginsburg R., Minobe W., β1 and β2 receptors are coupled to adenylate cyclase in human ventricular myocardium. Circ. Res., 59:297-308, 1986
2. Feldman A.M., Experimental issues in assessment of G-protiens in cardiac disease, Circulation, 84:1852-1861, 1991
3. Dhalla N.S., Wang X., Sethi R., Das P.K., Beamish R.E., β-adrenergic linked signal mechanisms in failing hearts. Heart Failure Reviews 2:55-65, 1997
4. Lohse M.J., Molecular mechanisms of membrane receptor desensitization. Biochim. Biophys. Acta., 1179:171-188, 1993
5. Hammond H.K., Mechanisms for myocardial β-adrenergic receptor desensitization in heart failure. Circulation, 87:652-654, 1993
6. Bohm M., Gierschik P., Knorr A., Larisch K., Weismann K., Erdmann E., Desensitization of adenylyl cyclase and increase of Gi in cardiac hypertrophy due to acquired hypertension. Hypertension, 20:103-112, 1992
7. Marzo K.P., Frey M.J., Wilson J.R., Liang B.T., Manning D.R., Lanoce V., Molinoff P.B., β-adrenergic receptor-G-protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing. Circ. Res., 69:1546-1556, 1991
8. S and adenylyl cyclase activities in compensated left ventricular hypertrophy. In heart failure, only the impairment in adenylyl cyclase activation progresses. J. Clin. Invest., 87:293-298, 1991
9. Longabaugh J., Vatner D.E., Vatner S.F., Homcy C.J., Decreased stimulatory guanosine triphosphate binding protein in dogs with pressure overload left ventricular failure. J. Clin. Invest., 81:420-424, 1988
10. Shi B., Heavner J.E., McMahon K.K., Spallholz J.E., Dynamic changes in Gi levels in rat hearts associated with impaired heart function after myocardial infarction. Am. J. Physiol., 269:H1073-H1079, 1995
11. Kacimi R., Gerdes A.M., Alterations in G protein and MAP kinase signaling pathways during cardiac remodeling in hypertension and heart failure. Hypertension, 41:968-977, 2003
12. Wieland T., Mittmann C., Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system. Pharmacol. Ther., 97:95-115, 2003
13. Esposito G., Rapacciuolo A., Naga Prasad S.V., Rockman H.A., Cardiac hypertrophy: role of G protein-coupled receptors. J. Card. Fail., 8:S409-S414, 2002
14. Rapacciuolo A., Esposito G., Prasad S.V., Rockman H.A., G protein-coupled receptor signalling in vivo cardiac overload. Acta. Physiol. Scand., 173:51-57, 2001
15. Bohm M., Kirchmayr R., Erdmann E., Myocardial G-protein levels in patients with hypertensive cardiac hypertrophy, ischemic heart disease and cardiogenic shock. Cardiovasc. Res., 30:611-618, 1995
16. Feldman A.M., Cates A.E., Bristow M.R., Van D.C., Altered expression of α-subunits of G-proteins in failing human hearts. J. Mol. Cell. Cardiol., 21:359-365, 1989
17. Wollert K.C., Drexler H., The renin-angiotensin system and experimental heart failure. Cardiovasc. Res., 43:838-849, 1999
18. Ren B., Lukas A., Shao Q., Guo M., Takeda N., Aitken R.M., Dhalla N.S., Electrocardiographic changes and mortality due to myocardial infarction in rats with or without imidapril treatment. J. Cardiovasc. Pharmacol. Therapeut., 3:11-22, 1998
19. Kuizinga M.C., Smits J.F., Arends J.W., Daemen M.J.A.P., AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J. Mol. Cell. Cardiol., 30:425-434, 1998
20. Liu Y-H., Yang X-P., Sharov VG., Nass O., Sabbah H.N., Peterson E., Carretero O.A., Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J. Clin. Invest., 99:1926-1935, 1997
21. Gervais M., Fornes P., Richer C., Nisato D., Giudicelli J.F., Effects of angiotensin II AT1-receptor blockade on coronary dynamics, function, and structure in postischemic heart failure in rats. J. Cardiovasc. Pharmacol., 36:329-337, 2000
22. 2+-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy. J. Hypertension, 15:1001-1009, 1997
23. 2+ transport in heart failure due to myocardial infarction. J. Mol. Cell. Cardiol., 31:1663-1672, 1999
24. Wang J., Liu X., Ren B., Rupp H., Takeda N., Dhalla N.S., Modification of myosin gene expression by imidapril in failing heart due to myocardial infarction. J. Mol. Cell. Cardiol., 34:847-857, 2002
25. Tappia P.S, Liu S.Y, Shatadal S., Takeda N., Dhalla N.S, Panagia V., Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril. Am. J. Physiol., 277:H40-H49, 1999
26. Wang X., Dhalla N.S., Modification of β-adrenoceptor signal transduction pathway by genetic manipulation and heart failure. Mol. Cell. Biochem., 214:131-155, 2000
27. Sethi R., Dhalla N.S., Inotropic responses to isoproterenol in congestive heart failure subsequent to myocardial infarction in rats. J. Cardiac Failure, 5:391-399, 1995
28. Wang J., Liu X., Sentex E., Takeda N., Dhalla N.S., Increased expression of protein kinase C isoforms in heart failure due to myocardial infarction. Am. J. Physiol. Heart Circ. Physiol., 284:H2277-H2287, 2003
29. Sethi R., Dhalla K.S., Beamish R.E., Dhalla N.S., Differential changes in left and right ventricular adenylyl-cyclase activities in congestive heart failure. Am. J. Physiol., 272:H884-H893, 1997
30. Sethi R., Elimban V., Chapman D., Dixon I.M.C., Dhalla N.S., Differential alterations in left and right ventricular G-proteins in congestive heart failure due to myocardial infarction. J. Mol. Cell. Cardiol., 30:2153-2163, 1998
31. Choczynski P., Sacchi M., Single step methods of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal. Biochem., 162:156-159, 1987
32. Feldman A.M., Experimental issues in assessment of G-protein function in cardiac disease. Circulation, 84:1852-1861, 1991
33. Adamson P.B, Vanoli E., Mattera G.G., Germany R., Gagnol J.P., Carminati P., Schwartz P.J., Hemodynamic effects of a new inotropic compound, PST-2744, in dogs with chronic ischemic heart failure. J. Cardiovasc. Pharmacol., 42:169-173, 2003
34. Elsherif L., Ortines R.V., Saari J.T., Kang Y.J., Congestive heart failure in copper-deficient mice. Exp. Biol. Med. (Maywood), 228:811-817, 2003
35. Reiken S., Wehrens X.H., Vest J.A., Barbone A., Klotz S., Mancini D., Burkhoff D., Marks A.R., Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation, 107:2459-2466, 2003
36. Sarsero D., Russell F.D., Lynham J.A., Rabnott G., Yang I., Fong K.M., Li L., Kaumann A.J., Molenaar P., (-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta 1-adrenoceptor. Naunyn Schmiedebergs Arch. Pharmacol., 367:10-21, 2003
37. Calderone A., Bouvier M., Li K., Dysfunction of the beta and alpha adrenergic system in a model of congestive heart failure. The pacing-overdrive dog. Circ. Res., 69:332-333, 1991
38. Taussig R., Tang W.J., Hepler J.R., Gilman A.G., Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. J. Biol. Chem., 269:6093-6100, 1994
39. 2+) channels in G(i2)alpha gene knockout mouse hearts. Am. J. Physiol. Heart. Circ. Physiol., 280:H1989-1995, 2001
40. 2+ currents by acetylcholine in mouse pancreatic B cells. J. Physiol., 499:65-76, 1997
41. Wolfe J.T., Wang H., Howard J., Garrison J.C., Barrett P.Q., T-type calcium channel regulation by specific G-protein betagamma subunits. Nature, 424:209-213, 2003
42. Lader A.S., Xiao Y.F., Ishikawa Y., Cui Y., Vatner D.E., Vatner S.F., Homcy C.J., Cantiello H.F., Cardiac Gs alpha overexpression enhances L-type calcium channels through an adenylyl cyclase independent pathway. Proc. Natl. Acad. Sci., USA, 95:9669-9674, 1998